Feasibility of Coronary CT Angiography-derived Left Ventricular Long-Axis Shortening as an Early Marker of Ventricular Dysfunction in Transcatheter Aortic Valve Replacement.

Purpose: To evaluate the value of using left ventricular (LV) long-axis shortening (LAS) derived from coronary CT angiography (CCTA) to predict mortality in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Materials and Methods: Patients with severe AS who underwent CCTA for preprocedural TAVR planning between September 2014 and December 2019 were included in this retrospective study. CCTA covered the whole cardiac cycle in 10% increments. Image series reconstructed at end systole and end diastole were used to measure LV-LAS. All-cause mortality within 24 months of follow-up after TAVR was recorded. Cox regression analysis was performed, and hazard ratios (HRs) are presented with 95% CIs. The C index was used to evaluate model performance, and the likelihood ratio χ2 test was performed to compare nested models. Results: The study included 175 patients (median age, 79 years [IQR, 73-85 years]; 92 men). The mortality rate was 22% (38 of 175). When adjusting for predictive clinical confounders, it was found that LV-LAS could be used independently to predict mortality (adjusted HR, 2.83 [95% CI: 1.13, 7.07]; P = .03). In another model using the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM), LV-LAS remained significant (adjusted HR, 3.38 [95 CI: 1.48, 7.72]; P = .004), and its use improved the predictive value of the STS-PROM, increasing the STS-PROM C index from 0.64 to 0.71 (χ2 = 29.9 vs 19.7, P = .001). In a subanalysis of patients with a normal LV ejection fraction (LVEF), the significance of LV-LAS persisted (adjusted HR, 3.98 [95 CI: 1.56, 10.17]; P = .004). Conclusion: LV-LAS can be used independently to predict mortality in patients undergoing TAVR, including those with a normal LVEF.Keywords: CT Angiography, Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR), Cardiac, Outcomes Analysis, Cardiomyopathies, Left Ventricle, Aortic Valve Supplemental material is available for this article. © RSNA, 2022See also the commentary by Everett and Leipsic in this issue.

An Interpretable Chest CT Deep Learning Algorithm for Quantification of COVID-19 Lung Disease and Prediction of Inpatient Morbidity and Mortality.

RATIONALE AND OBJECTIVES: The burden of coronavirus disease 2019 (COVID-19) airspace opacities is time consuming and challenging to quantify on computed tomography. The purpose of this study was to evaluate the ability of a deep convolutional neural network (dCNN) to predict inpatient outcomes associated with COVID-19 pneumonia. MATERIALS AND METHODS: A previously trained dCNN was tested on an external validation cohort of 241 patients who presented to the emergency department and received a chest computed tomography scan, 93 with COVID-19 and 168 without. Airspace opacity scoring systems were defined by the extent of airspace opacity in each lobe, totaled across the entire lungs. Expert and dCNN scores were concurrently evaluated for interobserver agreement, while both dCNN identified airspace opacity scoring and raw opacity values were used in the prediction of COVID-19 diagnosis and inpatient outcomes. RESULTS: Interobserver agreement for airspace opacity scoring was 0.892 (95% CI 0.834-0.930). Probability of each outcome behaved as a logistic function of the opacity scoring (25% intensive care unit admission at score of 13/25, 25% intubation at 17/25, and 25% mortality at 20/25). Length of hospitalization, intensive care unit stay, and intubation were associated with larger airspace opacity score (p = 0.032, 0.039, 0.036, respectively). CONCLUSION: The tested dCNN was highly predictive of inpatient outcomes, performs at a near expert level, and provides added value for clinicians in terms of prognostication and disease severity.

Computed tomographic assessment of right ventricular long axis strain for prognosis after transcatheter aortic valve replacement.

OBJECTIVES: To investigate the predictive value of right ventricular long axis strain (RV-LAS) derived by cardiac computed tomography angiography (CCTA) for mortality in patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). METHODS: We retrospectively included patients with severe AS undergoing TAVR (n = 168, median 79 years). Parameters of RV function including RV-LAS and RV ejection fraction (RVEF) were assessed using pre-procedural systolic and diastolic CCTA series. The tricuspid annulus diameter (TAD) and diameter of the main pulmonary artery (mPA) were also assessed. All-cause mortality was recorded post-TAVR. Cox regression was used and results are presented with hazard ratio (HR) and 95% confidence interval (CI). Harrell's c-index was used to assess the performance of different models and the likelihood ratio test was used to compare nested models. RESULTS: Thirty-eight deaths (22.6%) occurred over a median follow-up of 21 months. RV-LAS > -11.42% (HR 2.86, 95% CI 1.44-5.67, p = 0.003), LVEF (HR 0.98, 95% CI 0.96-0.996; p = 0.02), TAD (HR 1.05, 95% CI 1.01-1.10, p = 0.02) and mPA diameter (HR 1.09, 95% CI 1.02-1.16, p = 0.01) were associated with mortality on univariable analysis. In a multivariable model, only RV-LAS (HR 2.36, 95% CI 1.04-5.36, p = 0.04) remained as an independent predictor of all-cause mortality. RV-LAS significantly improved the predictive power of the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) (c-index 0.700 vs 0.637; p = 0.01). CONCLUSION: RV-LAS was an independent predictor of all-cause mortality in patients with severe AS undergoing TAVR, outperformed anatomical markers such as TAD and mPA diameter, and could potentially improve the current risk-stratifying tool.

Additive value of epicardial adipose tissue quantification to coronary CT angiography-derived plaque characterization and CT fractional flow reserve for the prediction of lesion-specific ischemia.

OBJECTIVES: Epicardial adipose tissue (EAT) from coronary CT angiography (CCTA) is strongly associated with coronary artery disease (CAD). We investigated the additive value of EAT volume to coronary plaque quantification and CT-derived fractional flow reserve (CT-FFR) to predict lesion-specific ischemia. METHODS: Patients (n = 128, 60.6 ± 10.5 years, 61% male) with suspected CAD who had undergone invasive coronary angiography (ICA) and CCTA were retrospectively analyzed. EAT volume and plaque measures were derived from CCTA using a semi-automatic software approach, while CT-FFR was calculated using a machine learning algorithm. The predictive value and discriminatory power of EAT volume, plaque measures, and CT-FFR to identify ischemic CAD were assessed using invasive FFR as the reference standard. RESULTS: Fifty-five of 152 lesions showed ischemic CAD by invasive FFR. EAT volume, CCTA ≥ 50% stenosis, and CT-FFR were significantly different in lesions with and without hemodynamic significance (all p < 0.05). Multivariate analysis revealed predictive value for lesion-specific ischemia of these parameters: EAT volume (OR 2.93, p = 0.021), CCTA ≥ 50% (OR 4.56, p = 0.002), and CT-FFR (OR 6.74, p < 0.001). ROC analysis demonstrated incremental discriminatory value with the addition of EAT volume to plaque measures alone (AUC 0.84 vs. 0.62, p < 0.05). CT-FFR (AUC 0.89) showed slightly superior performance over EAT volume with plaque measures (AUC 0.84), however without significant difference (p > 0.05). CONCLUSIONS: EAT volume is significantly associated with ischemic CAD. The combination of EAT volume with plaque quantification demonstrates a predictive value for lesion-specific ischemia similar to that of CT-FFR. Thus, EAT may aid in the identification of hemodynamically significant coronary stenosis. KEY POINTS: • CT-derived EAT volume quantification demonstrates high discriminatory power to identify lesion-specific ischemia. • EAT volume shows incremental diagnostic performance over CCTA-derived plaque measures in detecting lesion-specific ischemia. • A combination of plaque measures with EAT volume provides a similar discriminatory value for detecting lesion-specific ischemia compared to CT-FFR.

Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement.

BACKGROUND. Cardiac CTA is required for preprocedural workup before transcatheter aortic valve replacement (TAVR) and can be used to assess functional parameters of the left atrium (LA). OBJECTIVE. We aimed to evaluate the utility of functional and volumetric LA parameters derived from cardiac CTA to predict mortality in patients with severe aortic stenosis (AS) undergoing TAVR. METHODS. This retrospective study included 175 patients with severe AS (92 men, 83 women; median age, 79.0 years) who underwent cardiac CTA for clinical pre-TAVR assessment. A postdoctoral research fellow calculated maximum and minimum LA volumes using biplane area-length measurements; these values were indexed to body surface area, and maximum and minimum LA volume index (LAVImax and LAVImin, respectively) values were calculated. The LA emptying fraction (LAEF) was automatically calculated. All-cause mortality within a 24-month follow-up period after TAVR was recorded. To identify parameters predictive of mortality, Cox regression analysis was performed, and results were summarized by hazard ratio (HR) and 95% CI. The Harrell C-index was used to assess model performance. A radiology resident repeated the measurements in a random sample of 20% (n = 35) of the cases, and interobserver agreement was computed using the intraclass correlation coefficient (ICC). RESULTS. Thirty-eight deaths (21.7%) were recorded within a median follow-up of 21 months. LAVImax (HR, 1.02 [95% CI, 1.01-1.04]; p = .01), LAVImin (HR, 1.02 [95% CI, 1.01-1.04]; p < .001), and LAEF (HR, 0.97 [95% CI, 0.95-0.99]; p = .002) were predictive of mortality in univariable analysis. After adjusting for clinical parameters, only LAEF (HR, 0.97 [95% CI, 0.94-0.99]; p = .02) independently predicted mortality. The C-index of the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) significantly increased from 0.636 to 0.683, 0.694, and 0.700 when incorporating into the model LAVImax, LAVImin, and LAEF, respectively. The ICC for maximum and minimum LA volumes and LAEF ranged from 0.94 to 0.99. CONCLUSION. LAEF derived from preprocedural cardiac CTA independently predicts mortality in patients with severe AS undergoing TAVR. CLINICAL IMPACT. Cardiac CTA-derived LA function, evaluated during pre-TAVR workup, can be used to assess preprocedural risk and may improve risk stratification in post-TAVR surveillance.